Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

APRESOLINE-ESIDRIX

HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Standard Dose
25MG;15MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview APRESOLINE-ESIDRIX is listed in Drugs@FDA under application 012026 (NDA).

Marketing status: Discontinued Active ingredient HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 25MG;15MG Sponsor NOVARTIS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview APRESOLINE-ESIDRIX is listed in Drugs@FDA under application 012026 (NDA). Marketing status: Discontinued Active ingredient HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 25MG;15MG Sponsor NOVARTIS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.